Cargando…
Drug–Drug Interactions and Pharmacogenomic Evaluation in Colorectal Cancer Patients: The New Drug-PIN(®) System Comprehensive Approach
Drug–drug interactions (DDIs) can affect both treatment efficacy and toxicity. We used Drug-PIN(®) (Personalized Interactions Network) software in colorectal cancer (CRC) patients to evaluate drug–drug–gene interactions (DDGIs), defined as the combination of DDIs and individual genetic polymorphisms...
Autores principales: | Roberto, Michela, Rossi, Alessandro, Panebianco, Martina, Pomes, Leda Marina, Arrivi, Giulia, Ierinò, Debora, Simmaco, Maurizio, Marchetti, Paolo, Mazzuca, Federica |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7830292/ https://www.ncbi.nlm.nih.gov/pubmed/33467633 http://dx.doi.org/10.3390/ph14010067 |
Ejemplares similares
-
Optimising migraine treatment: from drug-drug interactions to personalized medicine
por: Pomes, Leda Marina, et al.
Publicado: (2019) -
Individualized Drugs’ Selection by Evaluation of Drug Properties, Pharmacogenomics and Clinical Parameters: Performance of a Bioinformatic Tool Compared to a Clinically Established Counselling Process
por: Borro, Marina, et al.
Publicado: (2021) -
The Potential Role of Genomic Signature in Stage II Relapsed Colorectal Cancer (CRC) Patients: A Mono-Institutional Study
por: Roberto, Michela, et al.
Publicado: (2022) -
Electrochemotherapy for Solid Tumors: Literature Review and Presentation of a Novel Endoscopic Approach
por: Schipilliti, Francesca Matilde, et al.
Publicado: (2022) -
Pharmacogenomics-Guided Pharmacotherapy in Patients with Major Depressive Disorder or Bipolar Disorder Affected by Treatment-Resistant Depressive Episodes: A Long-Term Follow-Up Study
por: Del Casale, Antonio, et al.
Publicado: (2022)